| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.003 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.004 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.007 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |